1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. GYRE THERAPEUTICS INC
Gyre Therapeutics Inc
XNAS: GYRE
6.55 -0.45 (-6.43%)
94,305
XNAS Volume

XNAS 15 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Gyre Therapeutics Inc - GYRE - stock price prediction, stock price target, analyst ratings from 3 analysts

Gyre Therapeutics Inc has a share price target of US$ 19, revenue growth forecast of -12.3%, and profit growth estimate of -480.7% for FY26, based on top 3 analyst calls.